InvestorsHub Logo
Followers 31
Posts 902
Boards Moderated 0
Alias Born 12/23/2009

Re: mojojojo post# 76570

Friday, 03/09/2012 2:11:36 PM

Friday, March 09, 2012 2:11:36 PM

Post# of 345989
Maybe things are not that bad or in other words FINAL

Rereading the report:
"We are pleased that the PFS results for the bavituximab-containing arm by both local and central image interpretation actually met or exceeded our expectations going into the study. While the data from the investigator assessments..."

And "Progression-free survival (PFS) denotes the chances of staying free of disease progression for a group of individuals suffering from a cancer after a particular treatment. It is the percentage of individuals in the group whose disease is likely to remain stable (and not show signs of progression) after a specified duration of time."

So I agree with you MOJO that this may be an interpretation matter. However OS will tell who was right.

How precise the local and central image interpretation is? That is the question
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News